Dr. Rafael Rosell is a highly respected figure in the field of oncology, with over four decades of experience dedicated to cancer research and treatment.

He serves as the Medical Director and President of the Dr. Rosell Oncology Institute, which operates within prestigious medical institutions including Dexeus University Hospital, Teknon Medical Center, Sagrat Cor University Hospital, and the General University Hospital of Catalonia, all part of the Quirónsalud Group.

Since 1982, Dr. Rosell has been specializing in oncology, demonstrating a lifelong commitment to advancing the understanding and treatment of cancer.

He is renowned for his tireless efforts in researching a cure for cancer, contributing significantly to the scientific community's understanding of various aspects of oncology.

Dr. Rosell's expertise in translational oncology, particularly in large cell lung cancer, has earned him widespread recognition. He is a leading authority in this field and has organized and participated in numerous seminars and conferences worldwide.

At the Dr. Rosell Oncology Institute, Dr. Rosell leads a multidisciplinary team that collaborates closely with the Oncology Laboratory to provide molecular diagnosis and personalized treatments tailored to the genetic characteristics of each patient.

His dedication and contributions to lung cancer research have been acknowledged by prestigious publications, with The Lancet ranking him as the top European leader in lung cancer in 2013.

Dr. Rosell's leadership at the institute ensures that patients receive cutting-edge care informed by the latest advancements in oncology research and personalized medicine.

He is not only a skilled clinician but also an effective communicator, regularly lecturing and sharing his expertise with colleagues and healthcare professionals worldwide.

Dr. Rafael Rosell's impact on the field of oncology is profound, and his work continues to improve outcomes for cancer patients while advancing the scientific understanding of the disease.